OGD Further Clarifies Residual Solvent Testing Requirements Under USP <467>
This article was originally published in The Gold Sheet
Executive Summary
No pre-approval required to change excipient suppliers under the Office of Generic Drug's interpretation of revised USP residual solvents standard.